Exercise Training and Endothelial Function in Type 1 Diabetes
- Conditions
- Type1diabetes
- Interventions
- Behavioral: Exercise Training ProcedureBehavioral: Normal life procedure
- Registration Number
- NCT03528226
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
Endothelial dysfunction and vasoreactivity disorders are early subclinical complications of type 1 diabetes (T1D). In a preventive setting, in T1D patients still free of complications, the research of non-pharmacological interventions to improve endothelial function appears fundamental.
In this randomized controlled trial, the effects of exercise training on endothelial function will be evaluated in T1D adults. Secondary objectives are to evaluate the exercise training effects on the micro and macrovascular function and exercise-induced tissue vasoreactivity and their possible neurometabolic consequences.
An improvement in vascular function, particularly endothelium-dependent, as well as in neurometabolic profile, through this non-pharmacological strategy is expected
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 34
- Covered by social security
- With a T1Diabete, diagnosed for at least 1 year, and free from macrovascular and microvascular diabetic complications.
- type 1 diabetes diagnoses for less than 1 year
- MODY diabetes, mitochondrial diabetes or type 2 diabetes
- presence of macrovascular and/or microvascular diabetic complications (retinopathy, nephropathy, neuropathy ,...)
- Obesity (Body Mass Index > 30 kg/m²
- Smokers
- Hypertension
- Disabling painful discomfort for trunk, upper or lower limb movements
- Active chronic disease or in remission (excluding type 1 diabetes)
- Head trauma in the past
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Exercise Training Exercise Training Procedure - Control Normal life procedure -
- Primary Outcome Measures
Name Time Method Change in percent flow-mediated dilation (FMD) values between baseline and at 4 months
- Secondary Outcome Measures
Name Time Method Change in percent flow-mediated dilation (FMD) values between baseline and at 2 months Change Blood marker concentrations of nitric oxide (NO) at baseline , at 2 months , at 4 months Change the vascular responses at baseline , at 2 months , at 4 months Endothelium-dependent vasodilation capacity induced by post-occlusive reactive hyperaemia (5min occlusion) at the level of microcirculation (skin capillaries and arterioles of the hand)
-Evolution of the blood volume at the vastus lateralis muscle and the prefrontal cortex in response to an incremental maximal exerciseBody composition (DEXA) at baseline , at 2 months , at 4 months change the maximum oxygen consumption ( VO2max) at baseline , at 2 months , at 4 months change Blood concentration of neurotrophic factors at baseline , at 2 months , at 4 months Blood concentration of neurotrophic factors and blood markers of metabolic profile
Trial Locations
- Locations (1)
Hop Claude Huriez Chu Lille
🇫🇷Lille, France